Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Semnur Pharmaceuticals, Inc.

OTC: SMNR · Life Sciences · 1 alert · CIK 1913577

Share price
$0.4700Close, Nov 13
Market cap
$102M
Shares outstanding
217.71MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Semnur Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:18 PM ET 10-Q
Financial Results

Semnur Pharmaceuticals Q3 2026 Results: Net Loss of $3.63M, Loss Narrows

Semnur Pharmaceuticals reported a net loss of $12.56 million for the nine months ended September 30, 2026, increasing its accumulated deficit to $288.36 million. The company maintains a significant stockholders' deficit of $33.31 million and relies heavily on a related party loan of $24.04 million to fund its operations.

Key figure
Net loss $3.63M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.